Psoriasis Resources - PsoriasisSupport.com
Psoriasis Resources - PsoriasisSupport.com. Get the facts about psoriasis from PsoriasisSupport.com. Learn Free Psoriasis Seminar. Join
|
Biogen Launches PsoriasisSupport.com
com. This site marks an important first step as we begin to forge a relationship between Biogen and psoriasis patients. This US
|
Dave's Psoriasis Info - DMARDs and Biologics Index
Psoriasis; Psoriasis Relief, at a Price (March 4, 2003); Biogen Stock; FDA OKs Unique New Psoriasis Treatment (January 31, 2003); Cincinatti
|
Tennessee Clinical Research Center - Clinical Research Studies
2001. · Psoriasis study (cont), · Biogen. · Psoriasis 724 study, · Biogen. Acne study, · Galderma. · Biogen Psoriasis study, · Biogen. · Epilight Preset vs.
|
Corporate Partners
Also dedicated to education people about psoriasis, Biogen Idec launched PsoriasisSupport.com, which offers patients useful articles, advice, and a supportive
|
Psoriasis Foundation Receives Gift from Biogen
10, 2003?The National Psoriasis Foundation received a gift of $20,000 from the biotechnology company Biogen at the International Psoriasis Symposium in late
|
Information on psoriasis treatment, symptoms, causes and cure.
Supported through an educational grant from Psoriasis Support, a psoriasis educational initiative of Biogen Idec.
|
Amevive - Treatment for Psoriasis
US Food and Drug Administration (FDA) approved alefacept (Amevive) for treatment of moderate to severe plaque psoriasis. Amevive, manufactured by Biogen, is an
|
Pharma Marketletter: Harsh blow for Biogen as psoriasis drug
Access the article, 'Harsh blow for Biogen as psoriasis drug Amevive stumbles in Europe. ' from Pharma Marketletter, a publication
|
Biogen licences oral psoriasis therapy from Fumapharm AG
Biogen licences oral psoriasis therapy from Fumapharm AG. Cambridge, Massachusetts, October 1 /PRNewswire/ -- - Phase III clinical
|
The Step Into My Skin
The Step Into My Skin web site, sponsored by Biogen Idec and the National Psoriasis Foundation, is no longer available. For more
|
News - FDA Advisory Committee Recommends Approval of Biogen's
to recommend approval of Amevive® (alefacept) for the treatment of moderate-to-severe chronic plaque psoriasis. Burt A. Adelman, MD, Biogen's Executive Vice
|
Patients Show Improvement in Phase II Psoriasis Study of Novel
and CEO of Fumapharm said, "Our partnership with Biogen Idec positions us well to jointly develop this promising approach to treating psoriasis." Other Phase
|
Fool.com: Using the Foolish Biotech Checklist (Stock Research)
Beyond Avonex, Biogen has only one other drug in late stage clinical trials -- Amevive, which treats the skin disorder psoriasis.
|
Biogen girds for battle in MS market - Biotech firm readies second
Still, Amevive has its share of fans on Wall Street, who point out that Biogen's psoriasis treatment will likely be the first and that the company has already
|
amevive drug information, amevive side effects
severe psoriasis, Biogen announced today. Amevive is the first biologic drug approved for www.psoriasis.org (Additional listing).
|
amevive drug information, amevive side effects
severe psoriasis, Biogen announced today. Amevive is the first biologic drug approved for www.psoriasis.org (Additional listing).
|
PATIENTS SHOW IMPROVEMENT IN PHASE II PSORIASIS STUDY OF NOVEL
D., President and CEO of Fumapharm said, "Our partnership with Biogen Idec positions us well to jointly develop this promising approach to treating psoriasis.".
|
Biogen to file Amevive data, no new studies - 2002-06-14
Related Topics. » Biogen's psoriasis drug to launch next year 2002-09-13, Boston. » Biogen Amevive psoriasis drug wins FDA backing
|
US Pharmacist
Amevive, Alefacept, Biogen, Psoriasis, 1/30/03 B. Biogen, Cambridge, MA (02/2003). Vega C. Alefacept Effective, Well Tolerated for Plaque Psoriasis.
|
Psoriasis: in search of the 'Holy Grail'
in filing, monoclonal antibodies from both Abgenix and Protein Design Labs have failed in psoriasis, and the FDA advisory panel opinion on Biogen's Amevive has
|
Newly Approved Drug Therapies (820): Amevive (alefacept), Biogen
presentations. Company: Biogen Approval Status: Approved January 2003 Treatment for: Psoriasis. General Information. Amevive (alefacept
|
Study of an oral fumarate shows improvement in psoriasis
and CEO of Fumapharm said, "Our partnership with Biogen Idec positions us well to jointly develop this promising approach to treating psoriasis." Other Phase
|
Psoriasis
psoriasis genitals psoriasis of the penis silkis psoriasis milk thistle psoriasis psoriasis faq psoriasis forums biogen and psoriasis lomalux psoriasis
|
Amevive approved for chronic plaque psoriasis
Alefacept (Amevive-Biogen) is the first biologic therapy for psoriasis, and is indicated for adults with moderate to severe plaque psoriasis, which is the most
|
